222 related articles for article (PubMed ID: 19620403)
1. Attenuation of IgG immune complex-induced acute lung injury by silencing C5aR in lung epithelial cells.
Sun L; Guo RF; Gao H; Sarma JV; Zetoune FS; Ward PA
FASEB J; 2009 Nov; 23(11):3808-18. PubMed ID: 19620403
[TBL] [Abstract][Full Text] [Related]
2. Extracellular histones are essential effectors of C5aR- and C5L2-mediated tissue damage and inflammation in acute lung injury.
Bosmann M; Grailer JJ; Ruemmler R; Russkamp NF; Zetoune FS; Sarma JV; Standiford TJ; Ward PA
FASEB J; 2013 Dec; 27(12):5010-21. PubMed ID: 23982144
[TBL] [Abstract][Full Text] [Related]
3. Expression of the complement anaphylatoxin C3a and C5a receptors on bronchial epithelial and smooth muscle cells in models of sepsis and asthma.
Drouin SM; Kildsgaard J; Haviland J; Zabner J; Jia HP; McCray PB; Tack BF; Wetsel RA
J Immunol; 2001 Feb; 166(3):2025-32. PubMed ID: 11160252
[TBL] [Abstract][Full Text] [Related]
4. Complement C5a exacerbates acute lung injury induced through autophagy-mediated alveolar macrophage apoptosis.
Hu R; Chen ZF; Yan J; Li QF; Huang Y; Xu H; Zhang X; Jiang H
Cell Death Dis; 2014 Jul; 5(7):e1330. PubMed ID: 25032853
[TBL] [Abstract][Full Text] [Related]
5. C5L2, the Second C5a Anaphylatoxin Receptor, Suppresses LPS-Induced Acute Lung Injury.
Wang R; Lu B; Gerard C; Gerard NP
Am J Respir Cell Mol Biol; 2016 Nov; 55(5):657-666. PubMed ID: 27285858
[TBL] [Abstract][Full Text] [Related]
6. Experimental design of complement component 5a-induced acute lung injury (C5a-ALI): a role of CC-chemokine receptor type 5 during immune activation by anaphylatoxin.
Russkamp NF; Ruemmler R; Roewe J; Moore BB; Ward PA; Bosmann M
FASEB J; 2015 Sep; 29(9):3762-72. PubMed ID: 25999468
[TBL] [Abstract][Full Text] [Related]
7. Contribution of the anaphylatoxin receptors, C3aR and C5aR, to the pathogenesis of pulmonary fibrosis.
Gu H; Fisher AJ; Mickler EA; Duerson F; Cummings OW; Peters-Golden M; Twigg HL; Woodruff TM; Wilkes DS; Vittal R
FASEB J; 2016 Jun; 30(6):2336-50. PubMed ID: 26956419
[TBL] [Abstract][Full Text] [Related]
8. C5a anaphylatoxin is a major regulator of activating versus inhibitory FcgammaRs in immune complex-induced lung disease.
Shushakova N; Skokowa J; Schulman J; Baumann U; Zwirner J; Schmidt RE; Gessner JE
J Clin Invest; 2002 Dec; 110(12):1823-30. PubMed ID: 12488432
[TBL] [Abstract][Full Text] [Related]
9. Macrophages induce the inflammatory response in the pulmonary Arthus reaction through G alpha i2 activation that controls C5aR and Fc receptor cooperation.
Skokowa J; Ali SR; Felda O; Kumar V; Konrad S; Shushakova N; Schmidt RE; Piekorz RP; Nürnberg B; Spicher K; Birnbaumer L; Zwirner J; Claassens JW; Verbeek JS; van Rooijen N; Köhl J; Gessner JE
J Immunol; 2005 Mar; 174(5):3041-50. PubMed ID: 15728518
[TBL] [Abstract][Full Text] [Related]
10. Distinct tissue site-specific requirements of mast cells and complement components C3/C5a receptor in IgG immune complex-induced injury of skin and lung.
Baumann U; Chouchakova N; Gewecke B; Köhl J; Carroll MC; Schmidt RE; Gessner JE
J Immunol; 2001 Jul; 167(2):1022-7. PubMed ID: 11441111
[TBL] [Abstract][Full Text] [Related]
11. Treatment with anti-C5aR mAb leads to early-onset clinical and mechanistic effects in the murine delayed-type hypersensitivity arthritis model.
Atkinson SM; Nansen A; Usher PA; Sondergaard BC; Mackay CR; Friedrichsen B; Chang CC; Tang R; Skov S; Haase C; Hornum L
Autoimmunity; 2015; 48(7):460-70. PubMed ID: 25915570
[TBL] [Abstract][Full Text] [Related]
12. Targeting complement anaphylatoxin C5a receptor in hyperoxic lung injury in mice.
Xu Y; Tian Z; Xie P
Mol Med Rep; 2014 Oct; 10(4):1786-92. PubMed ID: 25050483
[TBL] [Abstract][Full Text] [Related]
13. C5a/C5aR pathway accelerates renal ischemia-reperfusion injury by downregulating PGRN expression.
Zhang K; Li GQ; He QH; Li Y; Tang M; Zheng QY; Xu GL; Zhang KQ
Int Immunopharmacol; 2017 Dec; 53():17-23. PubMed ID: 29031143
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of complement C5a receptor protects lung cells and tissues against lipopolysaccharide-induced injury via blocking pyroptosis.
Wang R; Wang Y; Hu L; Lu Z; Wang X
Aging (Albany NY); 2021 Mar; 13(6):8588-8598. PubMed ID: 33714207
[TBL] [Abstract][Full Text] [Related]
15. Role of the C5a receptor (C5aR) in acute and chronic dextran sulfate-induced models of inflammatory bowel disease.
Johswich K; Martin M; Bleich A; Kracht M; Dittrich-Breiholz O; Gessner JE; Suerbaum S; Wende E; Rheinheimer C; Klos A
Inflamm Bowel Dis; 2009 Dec; 15(12):1812-23. PubMed ID: 19714742
[TBL] [Abstract][Full Text] [Related]
16. Requirement and role of C5a in acute lung inflammatory injury in rats.
Mulligan MS; Schmid E; Beck-Schimmer B; Till GO; Friedl HP; Brauer RB; Hugli TE; Miyasaka M; Warner RL; Johnson KJ; Ward PA
J Clin Invest; 1996 Jul; 98(2):503-12. PubMed ID: 8755663
[TBL] [Abstract][Full Text] [Related]
17. Regulation of inflammation by Rac2 in immune complex-mediated acute lung injury.
Dooley JL; Abdel-Latif D; St Laurent CD; Puttagunta L; Befus D; Lacy P
Am J Physiol Lung Cell Mol Physiol; 2009 Dec; 297(6):L1091-102. PubMed ID: 19801448
[TBL] [Abstract][Full Text] [Related]
18. Silencing of C5a receptor gene with siRNA for protection from Gram-negative bacterial lipopolysaccharide-induced vascular permeability.
Liu ZM; Zhu SM; Qin XJ; Cheng ZD; Liu MY; Zhang HM; Liu DX
Mol Immunol; 2010 Mar; 47(6):1325-33. PubMed ID: 20138669
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological targeting of anaphylatoxin receptors during the effector phase of allergic asthma suppresses airway hyperresponsiveness and airway inflammation.
Baelder R; Fuchs B; Bautsch W; Zwirner J; Köhl J; Hoymann HG; Glaab T; Erpenbeck V; Krug N; Braun A
J Immunol; 2005 Jan; 174(2):783-9. PubMed ID: 15634899
[TBL] [Abstract][Full Text] [Related]
20. Cell-derived anaphylatoxins as key mediators of antibody-dependent type II autoimmunity in mice.
Kumar V; Ali SR; Konrad S; Zwirner J; Verbeek JS; Schmidt RE; Gessner JE
J Clin Invest; 2006 Feb; 116(2):512-20. PubMed ID: 16453025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
